ID   DOCK8_MOUSE             Reviewed;        2100 AA.
AC   Q8C147; Q6KAM7; Q6PIS0; Q7TMQ5; Q8CAP6; Q8K105; Q9DBQ2;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 4.
DT   07-APR-2021, entry version 129.
DE   RecName: Full=Dedicator of cytokinesis protein 8;
GN   Name=Dock8;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1581-2100 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Lung, Skin, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 967-2100 (ISOFORM 1).
RC   STRAIN=C57BL/6J, FVB/N, and FVB/N-3; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 992-2100 (ISOFORM 1).
RC   STRAIN=ICR; TISSUE=Embryonic tail;
RX   PubMed=15449545; DOI=10.1093/dnares/11.2.127;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Kitamura H., Nakagawa T., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of FLJ genes: the
RT   complete nucleotide sequences of 110 mouse FLJ-homologous cDNAs identified
RT   by screening of terminal sequences of cDNA clones randomly sampled from
RT   size-fractionated libraries.";
RL   DNA Res. 11:127-135(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-905 AND SER-1244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, DISRUPTION PHENOTYPE, AND POLYMORPHISM.
RX   PubMed=25713392; DOI=10.1073/pnas.1501554112;
RA   Krishnaswamy J.K., Singh A., Gowthaman U., Wu R., Gorrepati P.,
RA   Sales Nascimento M., Gallman A., Liu D., Rhebergen A.M., Calabro S., Xu L.,
RA   Ranney P., Srivastava A., Ranson M., Gorham J.D., McCaw Z.,
RA   Kleeberger S.R., Heinz L.X., Mueller A.C., Bennett K.L., Superti-Furga G.,
RA   Henao-Mejia J., Sutterwala F.S., Williams A., Flavell R.A.,
RA   Eisenbarth S.C.;
RT   "Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice
RT   results in defective dendritic cell migration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:3056-3061(2015).
RN   [8]
RP   FUNCTION, INTERACTION WITH LRCH1, TISSUE SPECIFICITY, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND MUTAGENESIS OF SER-1827.
RX   PubMed=28028151; DOI=10.1084/jem.20160068;
RA   Xu X., Han L., Zhao G., Xue S., Gao Y., Xiao J., Zhang S., Chen P.,
RA   Wu Z.Y., Ding J., Hu R., Wei B., Wang H.;
RT   "LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates
RT   experimental autoimmune encephalomyelitis.";
RL   J. Exp. Med. 214:209-226(2017).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.08 ANGSTROMS) OF 1787-2067 IN COMPLEX WITH HUMAN
RP   CDC42, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND DISRUPTION PHENOTYPE.
RX   PubMed=22461490; DOI=10.1182/blood-2012-01-407098;
RA   Harada Y., Tanaka Y., Terasawa M., Pieczyk M., Habiro K., Katakai T.,
RA   Hanawa-Suetsugu K., Kukimoto-Niino M., Nishizaki T., Shirouzu M., Duan X.,
RA   Uruno T., Nishikimi A., Sanematsu F., Yokoyama S., Stein J.V., Kinashi T.,
RA   Fukui Y.;
RT   "DOCK8 is a Cdc42 activator critical for interstitial dendritic cell
RT   migration during immune responses.";
RL   Blood 119:4451-4461(2012).
CC   -!- FUNCTION: Guanine nucleotide exchange factor (GEF) which specifically
CC       activates small GTPase CDC42 by exchanging bound GDP for free GTP
CC       (PubMed:28028151, PubMed:22461490). During immune responses, required
CC       for interstitial dendritic cell (DC) migration by locally activating
CC       CDC42 at the leading edge membrane of DC (PubMed:22461490,
CC       PubMed:25713392). Required for CD4(+) T-cell migration in response to
CC       chemokine stimulation by promoting CDC42 activation at T cell leading
CC       edge membrane (PubMed:28028151). Is involved in NK cell cytotoxicity
CC       controlling polarization of microtubule-organizing center (MTOC), and
CC       possibly regulating CCDC88B-mediated lytic granule transport to MTOC
CC       during cell killing (By similarity). {ECO:0000250|UniProtKB:Q8NF50,
CC       ECO:0000269|PubMed:22461490, ECO:0000269|PubMed:25713392,
CC       ECO:0000269|PubMed:28028151}.
CC   -!- SUBUNIT: Interacts (via DOCKER domain) with GTPase CDC42; the
CC       interaction activates CDC42 by exchanging GDP for GTP
CC       (PubMed:22461490). The unphosphorylated form interacts (via DOCKER
CC       domain) with LRCH1 (via LRR repeats); the interaction prevents the
CC       association between DOCK8 and CDC42 (PubMed:28028151). Interacts with
CC       CCDC88B (By similarity). {ECO:0000250|UniProtKB:Q8NF50,
CC       ECO:0000269|PubMed:22461490, ECO:0000269|PubMed:28028151}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8NF50}. Cell
CC       membrane {ECO:0000269|PubMed:22461490}; Peripheral membrane protein
CC       {ECO:0000305|PubMed:22461490}; Cytoplasmic side {ECO:0000305}. Cell
CC       projection, lamellipodium membrane {ECO:0000305|PubMed:22461490};
CC       Peripheral membrane protein {ECO:0000305|PubMed:22461490}; Cytoplasmic
CC       side {ECO:0000305}. Note=Enriched and co-localizes with GTPase CDC42 at
CC       the immunological synapse formed during T cell/antigen presenting cell
CC       cognate interaction. Translocates from the cytoplasm to the plasma
CC       membrane in response to chemokine CXCL12/SDF-1-alpha stimulation.
CC       {ECO:0000250|UniProtKB:Q8NF50}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8C147-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8C147-2; Sequence=VSP_027374, VSP_027375, VSP_027376;
CC   -!- TISSUE SPECIFICITY: Expressed in T cells (PubMed:28028151). Expressed
CC       in bone marrow-derived dendritic cells (PubMed:25713392).
CC       {ECO:0000269|PubMed:25713392, ECO:0000269|PubMed:28028151}.
CC   -!- DOMAIN: The DOCKER domain is necessary and sufficient for the GEF
CC       activity. {ECO:0000269|PubMed:22461490}.
CC   -!- PTM: In response to chemokine CXCL12/SDF-1-alpha stimulation,
CC       phosphorylated by PRKCA/PKC-alpha which promotes DOCK8 dissociation
CC       from LRCH1. {ECO:0000250|UniProtKB:Q8NF50}.
CC   -!- POLYMORPHISM: Strain C3H/HeJ mice harbor a point mutation in Dock8
CC       which results in impaired dendritic cell migration. The mutation is not
CC       observed in strains CBA/J, C3H/HeOuJ or C3HeB/FeJ.
CC       {ECO:0000269|PubMed:25713392}.
CC   -!- DISRUPTION PHENOTYPE: Mice are viable and fertile (PubMed:22461490).
CC       The number of CD4(+) and CD8(+) T-cells are reduced by 50 percent in
CC       the spleen and peripheral lymph nodes (PubMed:22461490). The number of
CC       marginal zone B cells in the spleen are also reduced (PubMed:22461490).
CC       In response to an immune challenge, impaired migration of epidermal
CC       dendritic cells to the draining lymph nodes resulting in a failure to
CC       prime CD4(+) T-cells characterized by a lack of CD4(+) T-cell
CC       proliferation in lymph nodes and a lack of antigen-specific IgG
CC       antibody production (PubMed:25713392, PubMed:22461490).
CC       {ECO:0000269|PubMed:22461490, ECO:0000269|PubMed:25713392}.
CC   -!- SIMILARITY: Belongs to the DOCK family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00983}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH30316.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB23587.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC26219.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAD21430.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC139711; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC132319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK004816; BAB23587.1; ALT_INIT; mRNA.
DR   EMBL; AK028968; BAC26219.2; ALT_INIT; mRNA.
DR   EMBL; AK038285; BAC29959.1; -; mRNA.
DR   EMBL; BC029018; AAH29018.2; -; mRNA.
DR   EMBL; BC030316; AAH30316.2; ALT_INIT; mRNA.
DR   EMBL; BC043470; AAH43470.1; -; mRNA.
DR   EMBL; BC055295; AAH55295.1; -; mRNA.
DR   EMBL; AK131180; BAD21430.1; ALT_INIT; mRNA.
DR   CCDS; CCDS37943.1; -. [Q8C147-1]
DR   RefSeq; NP_083061.2; NM_028785.3. [Q8C147-1]
DR   PDB; 3VHL; X-ray; 2.08 A; A=1787-2067.
DR   PDBsum; 3VHL; -.
DR   SMR; Q8C147; -.
DR   BioGRID; 217953; 6.
DR   CORUM; Q8C147; -.
DR   IntAct; Q8C147; 5.
DR   STRING; 10090.ENSMUSP00000025831; -.
DR   iPTMnet; Q8C147; -.
DR   PhosphoSitePlus; Q8C147; -.
DR   SwissPalm; Q8C147; -.
DR   EPD; Q8C147; -.
DR   jPOST; Q8C147; -.
DR   PaxDb; Q8C147; -.
DR   PeptideAtlas; Q8C147; -.
DR   PRIDE; Q8C147; -.
DR   ProteomicsDB; 279760; -. [Q8C147-1]
DR   ProteomicsDB; 279761; -. [Q8C147-2]
DR   Antibodypedia; 758; 288 antibodies.
DR   Ensembl; ENSMUST00000025831; ENSMUSP00000025831; ENSMUSG00000052085. [Q8C147-1]
DR   GeneID; 76088; -.
DR   KEGG; mmu:76088; -.
DR   UCSC; uc008hba.1; mouse. [Q8C147-1]
DR   UCSC; uc008hbc.1; mouse. [Q8C147-2]
DR   CTD; 81704; -.
DR   MGI; MGI:1921396; Dock8.
DR   eggNOG; KOG1997; Eukaryota.
DR   GeneTree; ENSGT00940000155876; -.
DR   HOGENOM; CLU_000624_0_0_1; -.
DR   InParanoid; Q8C147; -.
DR   OMA; FVYPQRL; -.
DR   OrthoDB; 20156at2759; -.
DR   PhylomeDB; Q8C147; -.
DR   TreeFam; TF313629; -.
DR   Reactome; R-MMU-983231; Factors involved in megakaryocyte development and platelet production.
DR   BioGRID-ORCS; 76088; 1 hit in 53 CRISPR screens.
DR   ChiTaRS; Dock8; mouse.
DR   PRO; PR:Q8C147; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   RNAct; Q8C147; protein.
DR   Bgee; ENSMUSG00000052085; Expressed in granulocyte and 196 other tissues.
DR   Genevisible; Q8C147; MM.
DR   GO; GO:0031252; C:cell leading edge; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031256; C:leading edge membrane; ISO:MGI.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:MGI.
DR   GO; GO:1990869; P:cellular response to chemokine; ISO:MGI.
DR   GO; GO:0036336; P:dendritic cell migration; IMP:UniProtKB.
DR   GO; GO:0001771; P:immunological synapse formation; IMP:MGI.
DR   GO; GO:0061485; P:memory T cell proliferation; ISO:MGI.
DR   GO; GO:0070233; P:negative regulation of T cell apoptotic process; IMP:MGI.
DR   GO; GO:1903905; P:positive regulation of establishment of T cell polarity; IMP:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISO:MGI.
DR   GO; GO:2000406; P:positive regulation of T cell migration; IMP:UniProtKB.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd08696; C2_Dock-C; 1.
DR   Gene3D; 1.20.58.740; -; 1.
DR   Gene3D; 1.25.40.410; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   IDEAL; IID50262; -.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR037808; C2_Dock-C.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR027007; DHR-1_domain.
DR   InterPro; IPR027357; DHR-2.
DR   InterPro; IPR026791; DOCK.
DR   InterPro; IPR010703; DOCK_C.
DR   InterPro; IPR021816; DOCK_C/D_N.
DR   InterPro; IPR043161; DOCK_C_lobe_A.
DR   InterPro; IPR043162; DOCK_C_lobe_C.
DR   PANTHER; PTHR23317; PTHR23317; 1.
DR   Pfam; PF06920; DHR-2; 1.
DR   Pfam; PF14429; DOCK-C2; 1.
DR   Pfam; PF11878; DUF3398; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51650; C2_DOCK; 1.
DR   PROSITE; PS51651; DOCKER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Cytoplasm; Guanine-nucleotide releasing factor; Membrane; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..2100
FT                   /note="Dedicator of cytokinesis protein 8"
FT                   /id="PRO_0000189998"
FT   DOMAIN          561..730
FT                   /note="C2 DOCK-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00983"
FT   DOMAIN          1633..2067
FT                   /note="DOCKER"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00984"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NF50"
FT   MOD_RES         139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NF50"
FT   MOD_RES         452
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NF50"
FT   MOD_RES         905
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         937
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NF50"
FT   MOD_RES         1146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NF50"
FT   MOD_RES         1244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2088
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NF50"
FT   VAR_SEQ         1..366
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_027374"
FT   VAR_SEQ         1042..1044
FT                   /note="ESE -> VAV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_027375"
FT   VAR_SEQ         1045..2100
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_027376"
FT   MUTAGEN         1827
FT                   /note="S->P: In an experimental autoimmune
FT                   encephalomyelitis (EAE) disease model, 50 percent of
FT                   animals have no EAE symptoms. In the remaining animals, EAE
FT                   is less severe with a reduction in the demyelination of the
FT                   spinal cord and in the number of CD4(+) T-cells
FT                   infiltrating the central nervous system. In addition,
FT                   CD4(+) T-cell proliferation and apoptosis are increased.
FT                   Reduced CD4(+) T-cell transmigration towards chemokine
FT                   CXCL12 and CCL5."
FT                   /evidence="ECO:0000269|PubMed:28028151"
FT   CONFLICT        1608
FT                   /note="L -> M (in Ref. 2; BAC26219)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1616
FT                   /note="E -> K (in Ref. 3; AAH43470)"
FT                   /evidence="ECO:0000305"
FT   STRAND          1794..1802
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1803..1808
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1812..1820
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1823..1838
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1840..1842
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1843..1846
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1854..1856
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1861..1871
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1875..1878
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1891..1900
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1904..1906
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1910..1912
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1914..1927
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1929..1943
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1945..1965
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1971..1982
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   STRAND          1985..1987
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           1990..1997
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           2005..2035
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           2038..2040
FT                   /evidence="ECO:0007744|PDB:3VHL"
FT   HELIX           2041..2062
FT                   /evidence="ECO:0007744|PDB:3VHL"
SQ   SEQUENCE   2100 AA;  238978 MW;  E867E04339CC6009 CRC64;
     MATLPSAERR AFALKINRYS SSEIRKQFTL PPNLGQYHRH SISTSGFPSL QLPQLYEPVE
     PVDFEGLVMT HLNSLDAELA QELGDLTDDD LHVAFTPKEC RTLQHSLPEE GVELDPHVRD
     CVQTYIREWL IVNRKNQGSS EFCSFKKTGS RRDFQKTLQK QTFESETLEC SEPDTQTGPR
     HPLNVLCDVS GKGPLTSCDF DLRSLQPDER LENLLQLVSA EDFEKEKEEA RKTNRPAELF
     ALYPPVDEED AVEIRPVPEC PKEHLGNRIL VKVLTLKFEI EIEPLFASIA LYDVKERKKI
     SENFHCDLNS DQFKGFLRAH TPSIDPSSQA RSAVFSVTYP SSDIYLVVKI EKVLQQGEIA
     DCAEPYMIIK ESDGGKSKEK VEKLKLQAES FCQRLGKYRM PFAWAPISLA SFFNISTLER
     ESTDVEPGVG RNSVGEKRSL SQSRRPSERT LSLEENGVGS NFKATTLATN IFFKQEGDRL
     SDEDLFKFLA DYKRSSSLQR RVKSIPGSLR LEISPAPDVM NCCLTPEMLP VKPFPENRTR
     PHKEILEFPI REVYVPHTVY RNLLYVYPQR LNFASKLASA RNITIKIQFM CGEDPSNAMP
     VIFGKSSGPE FLQEVYTAIT YHNKSPDFYE EVKIKLPAKL TVNHHLLFTF YHISCQQKQG
     ASGESLLGYS WLPILLNERL QTGSYCLPVA LEKLPPNYSI HSAEKVPLQN PPIKWAEGHK
     GVFNIEVQAV SSVHTQDNHL EKFFTLCHSL ESQVSFPIRV LDQKITESTL EHELKLSIIC
     LNSSRLEPLV LFLHLVLDKL FQLSVQPMVI AGQTANFSQF AFESVVAIAN SLHNSKDLRK
     DQHGRNCLLA SYVHYVFRLP ELHRDTSKSG GPTTVVPDPR YHTYGRTSAA AVSSKLMQAR
     VMSSSNPDLT GSHCAADEEV KNIMSSKIAD RNCSRMSYYC SGNSDAPGST AAPRPVSKKH
     FHEELALQMV VSTGVVRETV FKYAWFFFEL LVKSMAQYVH NLDKRDSFRR TRFSDRFKDD
     ITTIVNVVTS EIAALLVKPQ KESEQAEKIN ISLAFFLYDL LSIMDRGFVF NLIKHYCSQL
     SAKLNILPTL ISMRLEFLRI LCSHEHYLNL NLLFMNTDTA PASPCPSISS QNSSSCSSFQ
     DQKIASMFDL TPEYRQQHFL TGLLFTELAV ALDAEGDGIS RVQRKAVSAI HSLLCSHDLD
     PRCRKPEVKV KIAALYLPLV GIILDALPQL YDFTDARSGR SRASGSYEEQ DVANGINQNV
     ALAIAGNHFN LKTSGAMLSS LPYKQYNMLN ADTTRHLMIC FLWIMKNADQ SLIRKWIADL
     PSMQLNRILD LLFICVSCFE YKGKQSSDKV SNQVLQKSRD VKAKLEEALL RGEGARGEMM
     RRRIPGTDRF PGINENLRWR KEQTQWRQAN EKLDKTKAEL DQEALISGNL ATEANLIILD
     MQENIIQASS ALDCKDSLLG GVLRVLVNSL SCDQSTTYLT HCFATLRALI AKFGDLLFEE
     EMEQCADLCQ RVLHHCSSSM DVTRSQACAT LYLLMRFSFG ATSNFARVKM QVTMALASLV
     GKAPDFNEEH LRRSLRTILA YSEEDTAMQT TPFPMQVEEL LCNLNSILYD TVKMREFQED
     PEMLMDLMYR IAKSYQASPD LRLTWLQNMA EKHTKKKCFT EAAMCLVHAA ALVAEYLSML
     EDHSYLPVGS VSFQNISSNV LEESAVSDDT LSPDEDGVCS GRYFTESGLV GLLEQAAELF
     STGGLYETVN EVYKLVIPIL EAHRDFRKLT STHDKLQKAF DNIINKDHKR MFGTYFRVGF
     YGSRFGDLDE QEFVYKEPAI TKLPEISHRL EGFYGQCFGA EFVEVIKDST PVDKTKLDPN
     KAYIQITFVE PYFDEYEMKD RVTYFEKNFN LRRFMYTTPF TLEGRPRGEL HEQHRRNTVL
     TTMHAFPYIK TRIRVSQKEE FVLTPIEVAI EDMKKKTLQL AVATHQEPPD AKMLQMVLQG
     SVGATVNQGP LEVAQVFLAE IPADPKLYRH HNKLRLCFKE FIMRCGEAVE KNRRLITAEQ
     REYQQELKKN YNKLRDSLRP MIERKIPELY KPIFRVDSQK RDSFHRSSFR KCETQLSQGS
//
